CoH's specialty is discovering new molecules and their mechanisms of action in the m6A mRNA space. Full stop. But they are superb at doing that. They run rings around RAC.
RAC's specialties are resurrecting old chemotherapy molecules, developing new formulations of old drugs, developing companion diagnostic tests, conducting preclinical trials (using contractors), conducting Phase 2 trials (using CROs).
Neither CoH nor RAC are good at Phase 3 trials or commercialisation. And they both know it.
- Forums
- ASX - By Stock
- RAC
- IGF2BP2 - Jianjun Chen's new mRNA target
IGF2BP2 - Jianjun Chen's new mRNA target, page-11
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.46 |
Change
-0.060(3.95%) |
Mkt cap ! $248.7M |
Open | High | Low | Value | Volume |
$1.53 | $1.55 | $1.46 | $123.6K | 82.48K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1 | $1.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.58 | 6715 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1 | 1.500 |
1 | 6800 | 1.470 |
2 | 9000 | 1.460 |
2 | 4770 | 1.455 |
3 | 12005 | 1.450 |
Price($) | Vol. | No. |
---|---|---|
1.580 | 6715 | 2 |
1.595 | 12136 | 1 |
1.600 | 33469 | 3 |
1.620 | 5327 | 1 |
1.645 | 10000 | 1 |
Last trade - 15.37pm 20/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online